125 related articles for article (PubMed ID: 18235975)
1. Insulin analogs with B24 or B25 phenylalanine replaced by biphenylalanine.
Du H; Shi J; Cui D; Zhang Y
Acta Biochim Biophys Sin (Shanghai); 2008 Feb; 40(2):133-9. PubMed ID: 18235975
[TBL] [Abstract][Full Text] [Related]
2. Two mutant forms of human insulin. Structural consequences of the substitution of invariant B24- or B25-phenylalanine by leucine.
Wollmer A; Strassburger W; Glatter U; Dodson GG; McCall M; Gattner HG; Danho W; Brandenburg D; Rittel W
Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):581-91. PubMed ID: 7024084
[TBL] [Abstract][Full Text] [Related]
3. Structural determinants of ligand recognition by type I insulin-like growth factor receptors: use of semisynthetic insulin analog probes.
Cara JF; Nakagawa SH; Tager HS
Endocrinology; 1988 Jun; 122(6):2881-7. PubMed ID: 2967179
[TBL] [Abstract][Full Text] [Related]
4. Mutations at the dimer, hexamer, and receptor-binding surfaces of insulin independently affect insulin-insulin and insulin-receptor interactions.
Shoelson SE; Lu ZX; Parlautan L; Lynch CS; Weiss MA
Biochemistry; 1992 Feb; 31(6):1757-67. PubMed ID: 1737029
[TBL] [Abstract][Full Text] [Related]
5. Structural integrity of the B24 site in human insulin is important for hormone functionality.
Žáková L; Kletvíková E; Veverka V; Lepsík M; Watson CJ; Turkenburg JP; Jirácek J; Brzozowski AM
J Biol Chem; 2013 Apr; 288(15):10230-40. PubMed ID: 23447530
[TBL] [Abstract][Full Text] [Related]
6. Cross-linking of a B25 azidophenylalanine insulin derivative to the carboxyl-terminal region of the alpha-subunit of the insulin receptor. Identification of a new insulin-binding domain in the insulin receptor.
Kurose T; Pashmforoush M; Yoshimasa Y; Carroll R; Schwartz GP; Burke GT; Katsoyannis PG; Steiner DF
J Biol Chem; 1994 Nov; 269(46):29190-7. PubMed ID: 7961885
[TBL] [Abstract][Full Text] [Related]
7. An insulin with the native sequence but virtually no activity.
Wollmer A; Gilge G; Brandenburg D; Gattner HG
Biol Chem Hoppe Seyler; 1994 Mar; 375(3):219-22. PubMed ID: 8011179
[TBL] [Abstract][Full Text] [Related]
8. Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor.
Xu B; Hu SQ; Chu YC; Huang K; Nakagawa SH; Whittaker J; Katsoyannis PG; Weiss MA
Biochemistry; 2004 Jul; 43(26):8356-72. PubMed ID: 15222748
[TBL] [Abstract][Full Text] [Related]
9. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects.
Nakagawa SH; Tager HS
J Biol Chem; 1986 Jun; 261(16):7332-41. PubMed ID: 3519607
[TBL] [Abstract][Full Text] [Related]
10. Semisynthesis and biological properties of the [B24-leucine]-, [B25-leucine[- and [B24-leucine, B25-leucine]-analogues of human insulin.
Inouye K; Watanabe K; Tochino Y; Kanaya T; Kobayashi M; Shigeta Y
Experientia; 1981; 37(8):811-3. PubMed ID: 7026270
[TBL] [Abstract][Full Text] [Related]
11. Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin.
Tager H; Thomas N; Assoian R; Rubenstein A; Saekow M; Olefsky J; Kaiser ET
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3181-5. PubMed ID: 6997872
[TBL] [Abstract][Full Text] [Related]
12. Semisynthetic insulin analogues modified in positions B24, B25 and B29.
Svoboda I; Brandenburg D; Barth T; Gattner HG; Jirácek J; Velek J; Bláha I; Ubik K; Kasicka V; Pospísek J
Biol Chem Hoppe Seyler; 1994 Jun; 375(6):373-8. PubMed ID: 7980868
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the dynamic behavior of monomeric and dimeric insulin shows structural rearrangements in the active monomer.
Zoete V; Meuwly M; Karplus M
J Mol Biol; 2004 Sep; 342(3):913-29. PubMed ID: 15342246
[TBL] [Abstract][Full Text] [Related]
14. Inactive conformation of an insulin despite its wild-type sequence.
Kurapkat G; De Wolf E; Grötzinger J; Wollmer A
Protein Sci; 1997 Mar; 6(3):580-7. PubMed ID: 9070440
[TBL] [Abstract][Full Text] [Related]
15. Disposition of the phenylalanine B25 side chain during insulin-receptor and insulin-insulin interactions.
Mirmira RG; Tager HS
Biochemistry; 1991 Aug; 30(33):8222-9. PubMed ID: 1868095
[TBL] [Abstract][Full Text] [Related]
16. Structure-function relationships of des-(B26-B30)-insulin.
Spoden M; Gattner HG; Zahn H; Brandenburg D
Int J Pept Protein Res; 1995; 46(3-4):221-7. PubMed ID: 8537175
[TBL] [Abstract][Full Text] [Related]
17. Aromatic anchor at an invariant hormone-receptor interface: function of insulin residue B24 with application to protein design.
Pandyarajan V; Smith BJ; Phillips NB; Whittaker L; Cox GP; Wickramasinghe N; Menting JG; Wan ZL; Whittaker J; Ismail-Beigi F; Lawrence MC; Weiss MA
J Biol Chem; 2014 Dec; 289(50):34709-27. PubMed ID: 25305014
[TBL] [Abstract][Full Text] [Related]
18. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
Záková L; Barth T; Jirácek J; Barthová J; Zórad S
Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of the superactive monomeric des-[Phe(B25)] human insulin mutant: elucidation of the structural basis for the monomerization of des-[Phe(B25)] insulin and the dimerization of native insulin.
Jørgensen AM; Olsen HB; Balschmidt P; Led JJ
J Mol Biol; 1996 Apr; 257(3):684-99. PubMed ID: 8648633
[TBL] [Abstract][Full Text] [Related]
20. Shortened insulin with enhanced in vitro potency.
Casaretto M; Spoden M; Diaconescu C; Gattner HG; Zahn H; Brandenburg D; Wollmer A
Biol Chem Hoppe Seyler; 1987 Jun; 368(6):709-16. PubMed ID: 3304338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
